Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1057 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-01-28 (businesswire.com)
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call | Business Wire
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
Read more
2025-01-13 (biospace.com)
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference -
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14th, at 2:15 p.m. PT (5:15 p.m. ET). Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.
Read more
2024-11-12 (marketscreener.com)
Charles River Laboratories to Present at UBS and Jefferies Conferences
Charles River Laboratories International, Inc. announced today that it will present at the UBS Global Healthcare Conference on Tuesday, November 12th, at 10:15 a.m. PT , and the Jefferies London...
Read more
2024-07-17 (sharewise.com)
Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2024 financial results on Wednesday, August 7th, before the market opens. A conference call has been scheduled
Read more
2024-04-11 (stocktitan.net)
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call | CRL Stock News
Charles River Laboratories International, Inc. (CRL) is set to release its first-quarter 2024 financial results on May 9th, with a conference call scheduled for 8:30 a.m. ET. Investors can access the live webcast and replay on the Company's Investor Relations website.
Read more
2023-11-27 (pharmaceuticaldaily.com)
Charles River Laboratories to Present at Evercore ISI Investor Conference
WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #CRL–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 6th Annual Evercore ISI HealthCO...
Read more
2023-10-16 (pharmaceuticaldaily.com)
Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #CRL–Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2023 financial results on Wednesday, November 8th...
Read more
2023-07-19 (businesswire.com)
Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
Read more
2023-06-05 (pharmiweb.com)
Charles River Laboratories to Present at William Blair and Jefferies Conferences
WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CRL--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6th, at 10:00 a.m. CT (11:00 a.m. ET), and at the Jefferies Global Healthcare Co...
Read more